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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   





















 Estimates suggest 1 in 5 
people worldwide (1.7 
billion, 22% of the world's 
population) have an 
underlying health 
condition that could 
increase their risk of 
severe COVID19 if 
infected. 
 Finding from a modelling 
study with data from 188 
countries 















 This SR discusses and 
highlights the limitations 





that would provide a more 
definitive analysis of the 





transmission in ongoing 
SARS-CoV-2 pandemic 
Infection Prevention and Control 
Publicatio
n date 
Title/URL Journal/Article type Summary Keyword
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 Clusters of 
coronavirus 
infections are often 




together, such as 
karaoke parties and 
and gym sessions, 
according to a 
survey in Japan. 
 Hitoshi Oshitani at 
Tohoku University 
in Sendai, Japan, 
and his colleagues 
analysed clusters of 
at least five infected 
people who had all 
attended the same 
event or venue (Y. 
Furuse et al. 
Emerg. Inf. Dis. 
http://doi.org/ggz2h





in hospitals, nursing 
homes and other 
care facilities, but a 
little more than half 
took place at 







Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type Author(s) 








15.06.20 Providing Care for Pediatric Cancer 
Patients in the COVID-19 Era: Rapid 
Response Recommendations From 
a Developing Country  
Pediatric blood and 







July 2020 Converging pandemics: implications 
of COVID-19 for the viral hepatitis 












Mary Afihene et 
al. 
15.06.20 Covid-19: Africa’s case numbers are 
rising rapidly, WHO warns 
BMJ | News Jacqui Thornton 
15.06.20 Continuing Community Outreach in 
the face of Covid-19 
IDS | Opinion Sophie Boudre, 
Charlotte Morgan 
15.06.20 COVID-19 lockdown in Zimbabwe: 
‘we are good at surviving, but things 
are really tough’ 
zimbabweland Ian Scoones 
12.06.20 Latin American scientists join the 
coronavirus vaccine race: ‘No one’s 
coming to rescue us’ 
Nature | news Emiliano 
Rodríguez Mega 
4 
15.06.20 World to hit 8 million confirmed 
coronavirus cases in next 24 hours 
New Scientist Adam Vaughan 
        
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
16.06.2020 Low-cost 
dexamethasone 
reduces death by up 









 Dexamethasone reduced 
deaths by one-third in 
ventilated patients and one fifth 
in other patients receiving 
oxygen only. There was no 
benefit for patients who did not 
require respiratory support. 
 1 death would be prevented by 
treatment of around 8 
ventilated patients or around 
25 patients requiring oxygen 
alone 
 Given the public health 
importance of these results, full 
details will be published shortly 
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  Sierra 
Leone 





US NIH  Our World 
in Data: C19 
Testing 




Our World in 
Data 






      
Global 5050 









  US  COVID-19 
Primer 




     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 




              
6 
C19 Resource Hubs 







Health Topics   Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 







  IDA 













































Cochrane  Center for Global 
Development 

















Institute of Public 
Health 









Oxford Centre for 
Evidence-based 
Medicine 
    




 HEART     
UNESCO   NEJM  UKRI     
UN WFP   Oxford 
University 
Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   Science  Prevent 
Epidemics  
    
Our World in 
Data 
  Springer 
Nature 




  SSRN 
(Preprints)  
      














WorldPop           
Flowminder           





    
  
Online learning & events 





Social, political, and 
public health factors 
fuelling the COVID19 
crisis in Brazil and 
Colombia 








Online course 1 hour WHO 
16.06.2020 Africa beyond COVID-
19 






Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 




WHO Academy and 
WHO Info mobile 
applications 






















Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr Peter 
Lachman, Dr Teri 
Rynolds & Dr Ed Kelley 




5 hours Johns Hopkins 






5 sessions 1h 30 International Initiative 











online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 





























the Novel Coronavirus 
Online 
learning 




































of Edinburgh & Royal 
College of Physicians 













Millington, K.A. and Reddin, S. (2020). COVID-19 Health Evidence Summary No.64. K4D 
Evidence Summary. Brighton, UK: Institute of Development Studies. 
Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
11 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
